1Ludwig J, Viggiano TR, McGill DB, et al . Non-alcoholic steatohepatitis. Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc, 1980,55 : 434-438 被引量：1
2Neuschwander-Tetri B, Caldwell S. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference.Hepatology, 2003, 37:1202-1219 被引量：1
3Szczepaniak LS, Nurenberg P,Leonard M D ,et al . Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endoerinol Metab, 2005,288 : E462-E468 被引量：1
4Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med, 2002,346 : 570-578 被引量：1
5Zhao AZ, Shinohara MM, Huang DM, et al . Bornfeldt leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. J Biol Chem, 2000,275 : 11348-11354 被引量：1
6Zhao AZ, Huan JN, Gupta S, et al . A phosphatidylinositol 3-kinase? phosphodiesterase 3B? cyclic AMP pathway in hypothalamic action of leptin on feeding. Nature Neuroscience, 2002,5 : 727-728 被引量：1
7Minokoshi Y, Kim YB, Peroni OD, et al.Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature ,2002,415:339-343 被引量：1
8Day CP. Non-alcoholic steatohepatitis (NASH) : where are we now and where are we going?, Gut ,2002,50 : 585-588 被引量：1
9Jequier E. Leptin signaling, adiposity, and energy balance.Ann NY Acad Sci ,2002,967 - 379-388 被引量：1
10Unger RH, Zhou YT, Orci L. Regulation of fatty acid homeostasis in cells, novel role of leptin. Proc Natl Acad Sci USA ,1999 ,96 :2327-2332 被引量：1
二级参考文献2
1Knobler H, Schattner A, Zhornicki T, et al. Fatty Liver-an additional and treatable feature of the insulin resistance syndrome. Q J M,1999,92:73-79. 被引量：1
2Day CP, James OF. Steatohepatitis-a tale of two''hits''? Gastroenterology, 1998,114: 842-845. 被引量：1
